(812) 309-78-59
(495) 223-46-76
ASTM E2549-14
Standard Practice for Validation of Seized-Drug Analytical Methods (Withdrawn 2023)
3 стр.
Отменен
Печатное изданиеЭлектронный (pdf)
93.60 $ (включая НДС 20%)
Разработчик:
Зарубежные/ASTM
ICS:
11.100.01 Laboratory medicine in general / Лабораторная медицина в целом
Сборник (ASTM):
14.02 Particle and Spray Characterization; Forensic Sciences; Accreditation & Certification; Forensic Psychophysiology; Nanotechnology; Forensic Engineering / Характеристика гранул и аэрозолей; Судебные науки; Аккредитация и сертификация; Судебная психофизиология; Нанотехнологии; Судебная инженерия
Тематика:
Forensic Sciences
Описание
Причина отменыThis practice addressed the validation of qualitative and quantitative seized-drug analytical methods. It discussed the validation of analytical methods in terms of their part in analytical schemes and in terms of performance characteristics including brief mention of measurement uncertainty and quality control parameters.

Formerly under the jurisdiction of Committee E30 on Forensic Sciences, this practice was withdrawn in July 2023 in accordance with section 10.6.3 of the Regulations Governing ASTM Technical Committees, which requires that standards shall be updated by the end of the eighth year since the last approval date.

Значение и использование

3.1 Validation is the confirmation by examination and the provision of objective evidence that the particular requirements for a specific intended use are fulfilled. There are numerous documents that address the topic of validation but there are few validation protocols for methods specific to seized drug analysis. This practice makes recommendations for the validation of both qualitative and quantitative methods used for the analysis of seized drugs.

Область применения

1.1 This practice addresses the validation of qualitative and quantitative seized-drug analytical methods. It discusses the validation of analytical methods in terms of their part in analytical schemes and in terms of performance characteristics including brief mention of measurement uncertainty and quality control parameters.

1.2 This practice does not replace knowledge, skill, ability, experience, education or training and should be used in conjunction with professional judgment.

1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Ключевые слова:
analytical scheme; methods; performance characteristics; seized-drug analytics; validation